New Enterprise Associates is up to its neck in initial public offerings these days. But even for NEA, a chipmaker IPO isn't exactly common.

One of the Chevy Chase-based venture capital firm's portfolio companies, Milpitas, Calif.-based Aquantia Corp., this week  announced a $16 million Series G financing led by Xilinx Inc., a possible prelude to a public offering for the decade-old semiconductor company, an executive  told The Wall Street Journal.

More than 21 startups presented their technology offerings to Exelon executives and IT employees at "Dancing with Startups," a two-day event hosted by Exelon and the Economic Alliance of Greater Baltimore at the University of Maryland, Baltimore County, and the Cyber Point Technology & Innovation Center last week.

The event is part of Exelon's continuing effort to reach out to technology innovators in search of new ideas that have the potential to transform the energy industry. From cybersecurity software to smartphone technology, participating companies pitched their ideas and products during rapid-fire, 20-minute sessions. Exelon employees peppered the groups with questions, seeking to identify new technologies that Exelon might be able to pilot.

People who are prone to bleeding due to poor blood clotting, such as those with hemophilia or on anticoagulants, are often required to take blood tests. These test are usually done in clinics and hospitals, adding to the patient’s burden and expense of extra travel just to make sure that blood is adequately anticoagulated. New technology that is being developed at Qloudlab, a startup based at École polytechnique fédérale de Lausanne (EPFL) in Switzerland, uses capabilities already present in today’s smartphone screens for blood coagulation testing.

Video games have been used in a number of therapeutic applications, such as managing pain in burn victims and helping youngsters deal with depression. A new project in Australia is bringing together video game technology with gesture recognition and some other components to create a virtual reality interactive environment for dementia patients and their caretakers. The project is still in the development stage, and is looking for crowdsourced funds, but the video below shows off the current prototype that will eventually include a 10 m x 10 m projection screen, a touch display, and special lighting.

Pharmaceutical companies have long relied on successfully launching new drugs to drive growth. This pressure is only likely to increase. Patents are expiring and product pipelines are shrinking. Austerity measures in many countries are increasing local and national hurdles for market access. And, at the same time, launches are becoming more numerous, smaller, and more competitive. We estimate that pharmaceutical companies will launch some 400 new products in the next three years, up 146 percent from 2005. Given this changing external landscape, awash with more products of ever greater diversity, it’s never been more important for pharmaceutical companies to crack the new-product launch code.

The University Economic Development Association (UEDA) is currently seeking nominations for its annual Awards of Excellence program, which recognizes cutting edge university-based economic development initiatives from across the country. The Awards of Excellence Program recognizes higher education institutions and their partners who are transforming their campuses into engines of economic prosperity through creative initiatives in five categories:

Don't take $5,000 from all your friends, Fortify Ventures Managing Director Jonathon Perrelli warns a founder over lunch in the second episode of “Startupland,” or "you're going to have 20 pains in the asses."

If “Startupland” — a documentary on early-stage entrepreneurship that premiered last week in D.C — does one thing well, it's depicting the complex and uneasy relationship founders have with outside capital. The above quote, in particular, is a particularly blunt reference to the pitfalls of the friends-and-family round, where a startup CEO risks adding a horde of impatient, inexperienced micromanagers to his cap table. It's a tension that runs throughout the first two episodes of “Startupland,” which was screened on March 13 at Landmark's E Street Cinema. Founders need early money, yet early money is expensive.

Small technology companies could get help hiring interns through a proposed program aimed at strengthening ties between businesses and universities.

Under a General Assembly bill, the Maryland Technology Internship Program would give 40 small businesses up to $3,000 a year to hire interns. The bill (HB1317) to create the program was approved by the state House of Delegates and is being considered by the Senate. If approved, Gov. Martin O’Malley would need to authorize funding for the program, estimated at $190,000 in fiscal 2015.

Commercializing technology doesn’t have to be all about patents, licenses and startups.

Universities looking to grow their influence in the technology sector often focus on patenting their own ideas, starting companies from faculty research and other strategies that keep new ideas in-house or on a leash. But Maryland’s technology industry relies on the talent coming out of local universities. And in order for the industry to grow and thrive, technology companies and universities will need to forge stronger bonds.

According to financial services firm Ernst&Young, global venture capital investment in 2013 increased 2 percent compared to 2012, to $48.5 billion. Meanwhile, economic conditions improved in many geographic markets due to increased levels of liquidity and a boost in investor confidence.

The upshot: More investors are competing to invest in promising startups and entrepreneurs, especially outside the U.S.

2014 will continue to be a year of transformation as the implementation of the Affordable Care Act and the changes it represents ripple through the healthcare industry. From conversations with healthcare providers across the country, Vree Health has identified four key issues providers face in the coming year–and beyond.

1. Healthcare reimbursement is due for a reboot

Healthcare systems, hospitals and providers are caught between two widely divergent business models: fee-for-service versus pay-for-performance. While dependent on the former, they must restructure their businesses to improve quality and manage costs across the entire care continuum to prepare for the latter. It’s an about face that Dr. David Nash, Founding Dean of the Jefferson School of Population Health, likened to turning an aircraft carrier around in the Panama Canal, when he spoke at MedCity CONVERGE last year.

Last year the California HealthCare Foundation (CHCF) put out a report on healthcare accelerator programs that we covered at the time. It is still the best summary of the health accelerator space. CHCF also created an infographic on how healthcare accelerators can maximize their value. The report focused on Rock Health, Startup Health, Blueprint Health, HealthBox, StartX Med, and TigerLabs.

Since that report was published, other health accelerators have launched and had classes, DreamIt and Wildcatters being the largest ones that come to mind. The accelerator landscape is getting attention right now with SXSW going on and accelerators are active at and around conferences. I thought it was time to revisit the subject.

The Tech Council of Maryland (TCM), Maryland's largest technology trade association, is pleased to announce that three members of its board have been named to a statewide private sector economic development commission. They are Douglas Doerfler, CEO of MaxCyte and TCM chairman; Dr. DeRionne Pollard, president of Montgomery College; and Christy Wyskiel, senior advisor for Enterprise Development at Johns Hopkins University.

AstraZeneca's global biologics R&D arm MedImmune and the University of Cambridge have entered into a three-year oncology research collaboration in order to advance cancer research by using imaging technologies to measure key biologic changes within growing tumors.

COLLEGE PARK, Md. — The $100K ACC Clean Energy Challenge, a business plan competition supported by the Department of Energy's (DOE) Office of Energy Efficiency and Renewable Energy (EERE) encouraging students from universities in the southeastern United States to develop business plans for new clean energy companies, today announces its Elite Eight Plus Two, with nine winners from ACC schools and one winner from the at-large, non-ACC pool of entrants.

University of Maryland students will host Bitcamp, the university's first Major League Hackathon, April 46, 2014 in Cole Field House on the university's College Park, Md., campus. More than 750 college and high school students from across the country are expected to attend the innovative technology summit at UMD.

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

Perhaps one of the most persistent struggles when dealing with anxiety is what people get wrong about the disorder.

According to Joseph Bienvenu, an associate professor of psychiatry and behavioral sciences at Johns Hopkins University, there are many fallacies when it comes to anxiety disorders, and that can make dealing with it more difficult. These misconceptions are a common reality for those who either have the condition, know someone who is battling it or think they may be on the brink of a diagnosis. We've debunked the 10 of the most common myths about anxiety and panic disorders.

Every day on my way to work, I walk past the “Deepthroat Garage,” the once-secret spot where The Washington Post’s Bob Woodward met FBI Associate Director Mark Felt to swap info that eventually brought down President Richard Nixon in The Watergate scandal. It is a spot that resonates deeply with people in Washington, marked with a historical placard for those who are passing by.

There is another historical marker 100 feet from that location that is nowhere near as popular but arguably more significant. Across the intersection where Wilson and Clarendon boulevards meet marks the spot where the Internet was invented.

Imagine a world in which everyone is empowered to take charge of their own health care by discovering their personal genetic risk factors. That's the vision of Anne Wojcicki, founder and CEO of the personalized gene-testing company 23andMe.

"How many people love the health care they're getting today?" Wojcicki asked a large audience here Sunday (March 9) at the South By Southwest Interactive festival. Only a handful of people raised their hands.

Health technology startups shone this year at South by Southwest Interactive.

Pedicab bikers raved about TumorPaint (the inventor of the “molecular flashlight” delivered a rousing talk), and Misfit Wearables piqued excitement by giving out 100 of its free fitness devices to attendees. And a mental health startup called ThriveOn beat out social networking apps to win Best of Show at the accelerator competition.

Here’s a testament to how 3D printing is making rapid prototyping more accessible to startups and entrepreneurs. Pictured here is a smartphone case designed and 3D printed by 15-year-old Suman Mulumudi, a student at Lakeside School in Seattle (where Bill Gates attended).

Mulumundi is also the CEO of Stratoscientific, a company he co-founded with his father, a cardiologist, to commercialize the case and another cardiology device he developed.

Featuring Chris Sasiela, PhD, RAC, Regulatory Strategist, Office of Translational Alliances and Coordination, NHLBI, this inaugural Hangout, “Navigating the FDA website,” will provide biomedical innovators with an overview of the types of information available on the U.S. Food and Drug Administration website including: organization charts, contact info, guidance documents, and more!   Key take-away points will include: -A guide to finding organization charts for the FDA’s Center for Devices and Radiological Health, Center for Drug Evaluation and Research, and Center for Biologics Evaluation and Research -Contact information for various Offices and Divisions -Contact information for Small Business Assistance contacts -Guidance documents -Public information related to product approvals that can be applied to your technology   Tune in and share out using the hashtag #SBIRChat .

MIT professor Yael V. Hochberg revealed the most effective startup accelerators in the country Tuesday at SxSW in Austin. DreamIt Health showed up in slot #15 and was the only health focused accelerator on the list.

Hochberg is a professor of Finance at the Sloan School of Management at the Massachusetts Institute of Technology. She and professor Susan Cohen of the University of Richmond and the Batten Institute at the University of Virginia’s Darden School of Business, used original research and data from CrunchBase to rank the 15 accelerators.

Juxtopia®’s (www.juxtopia.org) team, Juxtopia® Imhotep, formed as a program to create minority telemedicine companies to address telemedicine marketplace needs. The global telemedicine market grew from $9.8 billion in 2010 to $11.6 billion in 2011 and will almost triple to $27.3 billion in 2016, a compound annual growth rate (CAGR) of 18.6% over the next five years, according to a report from BCC Research.

Juxtopia® Imhotep officially entered the Qualcomm Tricorder X PRIZE http://www.qualcommtricorderxprize.org/ in January, 2014. In this X PRIZE competition, Juxtopia® Imhotep will compete with 31 teams around the world to engineer a consumer-friendly mobile telemedicine device that will measure vital signs and diagnose 15 health conditions including, but not limited to, diabetes, anemia, atrial fibrillation, stroke, tuberculosis, chronic obstructive pulmonary disease (COPD), pneumonia, and hepatitis.

DreamIt Ventures continues its investment in the health tech space by launching its third DreamIt Health program. We’ve previously covered the 2013 DreamIt Health Philadelphia program and the 2014 DreamIt Health Baltimore program, which is ongoing. Applications for the third class, which will be in Philadelphia from July 18th till November 9th, are currently being accepted until May 16th. If you have the next great startup idea for health, you can apply here….

We had the opportunity to speak with DreamIt Health Managing Partner, Elliot Menschik, MD, PhD, about the program and where he sees opportunities in health tech entrepreneurship.

The IPO wave kept rolling for venture-capital-backed biotech as two life science companies held their first trading day Friday, while another estimated a price range for its public debut and a fourth publicly filed its paperwork.

Reuters Shares of Aquinox Pharmaceuticals Inc. rose 8.6%, while Recro Pharma Inc.‘s stock rose 3.8%.

To celebrate Women’s Day, we hobnobbed with 24 year-old Silicon Valley-based high-tech startup founder Meredith Perry. She’s audacious, persistent, resourceful and a game changer in every sense. Perry’s start-up, uBeam, develops technology using ultrasound to wirelessly charge devices. In 2012, Mike Arrington hailed her demo as the “closest thing to magic” he had seen in a long time. Since, Silicon Valley powerhouses such as Marissa Mayer, Peter Theil, and Andressen Horowitz have invested in uBeam.

Perry designed the early prototypes of uBeam’s technology without any engineering degree, relying on in-depth Internet research and “begging professors to teach her extra concepts after class.” When she first brought her idea to experts and engineers she was met with point-blank responses along the lines of ‘you are trying to do the impossible; it will never work.’

A number of devices now exist that turn smartphones into medical monitors, but they tend to focus on specific vital signs and you’d have to carry a number of separate components to measure a variety of parameters. A new iPhone case called Wello from Azoi Inc. is planned to be released later this year combines a one lead ECG, thermometer, pulse oximeter, and supposedly even a cuffless blood pressure sensor in one device. It will also come with an optional spirometer for measuring airway flows and volumes.

Though other components are available in existing devices, cuffless blood pressure measurement is not trivial and has never been demonstrated to be as accurate as traditional cuffed BP monitors. And since FDA clearance is still required to release the Wello in the U.S., it will be interesting to see just how accurate it really is. Coincidentally, the Scanadu Scout, a device with similar claims, including cuffless blood pressure monitoring, is set to be shipped this month to all those who invested in it through an Indiegogo crowdfunding campaign.

Debt isn’t always a dirty word in the world of startups.

Yesterday I heard John Hoesley from Silicon Valley Bank give a brief presentation on venture debt as a funding mechanism for startups at a capital connections event hosted by BioOhio. He mentioned that SVB has seen an uptick in its venture debt business over the last few years as venture capital dollars have become more scarce and companies have turned to alternative sources of funding.

Alejandro Zaffaroni, a prolific biotechnology entrepreneur and Silicon Valley legend who played a significant role in the development of the birth control pill, the nicotine patch, the DNA chip and corticosteroids, died on Saturday at his home in Atherton, Calif. He was 91.

The cause was complications of dementia, Ana Leech, his longtime assistant, said.

REGISTRATION DEADLINE: MARCH 14

The 8th Annual Entrepreneurial University Startups Conference is organized annually by the National Council of Entrepreneurial Tech Transfer (NCET2.org). The University Startups Conference is a unique conference series dedicated exclusively to the best practices for creating and funding globally-competitive, venture-backable university startups.

We bring together universities creating startups with VCs, angel investors, SBIR program managers and Fortune 500 technology scouts funding them. The conference also includes NSF, NIH, NIST, DOD, DOE, DHS and other government agencies working on improving the Innovation Economy by increasing the quality and quantity of startups coming out of universities.

Fierce Biotech today published the top 15 sites in the US for biotech venture capital in 2013.  This according to figures from the National Venture Capital Association (NVCA) as compiled by Thomas Reuters.  The findings are not terribly surprising in terms of the rankings -- except it might be a mild surprise that San Francisco outspent Boston/Cambridge on the VC front last year.  Otherwise, the rankings look to make sense.  Here is the summary below in terms of place, dollars and numbers of deals.  The total dollars for the US was $4.5 B.

Silver Spring-based United Therapeutics (NASDAQ: UTHR) finished off 2013 with a strong showing, collecting revenues of over $1.1 billion for the first time in its corporate history as well posting a net profit for the full-year 2013 and upbeat 2014 outlook.

Hidden beneath all the earnings news is a very important line segment on the balance sheet called “Cash and Cash Equivalents”. These are assets that have high liquidity and can be easily converted to cash or are cash themselves; that being said United Therapeutics has amassed nearly $1.14 billion worth of it. The amount is over $350 million more than the company held at the end of 2012.

Startup incubator DreamIt Ventures Austin is kicking off a new microfund this week that will benefit the companies involved with its second accelerator program.

The microfund, which will run through a partnership with AngelList, allows accredited investors to crowdfund money for startups. Everyone who participates in DreamIt Austin’s microfund will need to make a $2,500 minimum investment that will fund all nine companies within DreamIt’s Austin program — that means you can’t just pick and chose to fund only the companies you like.